U.S. Steel Stocks Surge as Tariff Announcement Sparks Market Optimism
Shares of U.S. steel and aluminum companies soared in premarket trading on Monday following President Donald Trump’s announcement of a sweeping 25% tariff on all
Home
Page 168
January Jobs Report Shows Hiring Slowdown Signaling Economic Uncertainty
The U.S. labor market in January 2025 saw a hiring slowdown, with signs that companies are acting as if a recession is on the horizon,
Xtract One Technologies Enhances Hospital Security with Innovative Screening Solutions
Xtract One Technologies (TSX: XTRA, OTCQX: XTRAF) has secured a significant contract to implement its advanced Gateway weapon detection system at key healthcare facilities in
SoftBank Eyes Major OpenAI Investment, Valuing AI Leader at $260 Billion
SoftBank (Tokyo Stock Exchange Prime Market: 9984) is reportedly nearing a $40 billion investment in OpenAI, valuing the artificial intelligence company at $260 billion pre-money.
NFL Explores Technological Advancements for First Down Measurements
The NFL is exploring the potential of Sony’s Hawk-Eye optical tracking technology to modernize first-down measurements, replacing the traditional “chain gang”. This comes after a
CSL Behring’s Hemophilia B Gene Therapy, HEMGENIX®, Shows Sustained Efficacy in Long-Term Study
CSL Behring (ASX: CSL, OTCQX: CSLLY) has released four-year data from its Phase 3 HOPE-B trial, demonstrating the long-term efficacy and safety of its gene
A Rising Gold Price Environment – Highlights the Potential these Gold Explores
“Money is gold, nothing else,” J. P. Morgan famously said in 1912. The US investment bank, JP Morgan Chase, named after its founder is following
Knightscope Expands Operations to Washington, D.C. to Serve Federal Sector
Knightscope, Inc. (Nasdaq: KSCP), a developer of autonomous security robots (ASRs) and artificial intelligence (AI) technologies, is establishing operations in Washington, D.C. This move follows
Eli Lilly Fast-Tracks Retatrutide Data Release, Strengthening Position in Weight Loss Market
Eli Lilly (NYSE: LLY) has announced that data from a late-stage trial of its next-generation weight loss drug, retatrutide, is expected to be released later
MicroStrategy Rebrands to Strategy, Signaling Deeper Bitcoin Focus
MicroStrategy (NASDAQ: MSTR) has rebranded to “Strategy,” a move announced Wednesday that emphasizes the company’s dedication to its cryptocurrency strategy. Along with the new name,
